Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006

被引:38
|
作者
Goldacre, Michael J. [1 ]
Duncan, Marie [1 ]
Griffith, Myfanwy [1 ]
Turner, Martin R. [2 ]
机构
[1] Univ Oxford, Dept Publ Hlth, Unit Health Care Epidemiol, Oxford OX3 7LF, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
关键词
Multiple sclerosis; Motor neuron disease; Parkinson's disease; Epilepsy; Mortality; Trends; MORTALITY-RATES; MORBIDITY;
D O I
10.1007/s00415-009-5392-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this study is to report trends in mortality, as certified on death certificates, from multiple sclerosis (MS), motor neuron disease (MND), primary Parkinson's disease (PD), and epilepsy, analysing not only the underlying cause of death but also all certified causes for each disease. Death records in the Oxford region, 1979-2006, and England, 1996-2006, were analysed for ascertaining the trends in mortality. The percentage of deaths coded as the underlying cause changed over time, coinciding with changes to the rules for selecting the underlying cause of death. Changes over time to coding rules had a large impact on apparent trends in death rates for PD when studied by underlying cause alone. They also had significant, though smaller, effects on trends in death rates for MS, MND and epilepsy. Nationally, in the last period of the study, underlying cause mortality identified 64% of deaths with a mention of MS, 88% of MND, 56% of PD, and 48% of epilepsy. In the longstanding Oxford data from 1979 to 2006, death rates based on all certified causes of death showed no significant change for MS; an upward trend for MND (notably in women over 75), though only in the last few years of the study; a significant but small decline for PD; and no significant change for epilepsy. When mortality statistics are analysed by underlying cause only, their value is reduced. A substantial percentage of neurological deaths are missed. Time trends may be misleading. All certified causes for each disease, as well as the underlying cause, should be analysed.
引用
收藏
页码:706 / 715
页数:10
相关论文
共 50 条
  • [21] Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis
    Delgado-Alvarez, Alfonso
    Diez-Cirarda, Maria
    Delgado-Alonso, Cristina
    Hernandez-Lorenzo, Laura
    Cuevas, Constanza
    Valles-Salgado, Maria
    Montero-Escribano, Paloma
    Gil-Moreno, Maria Jose
    Matias-Guiu, Jorge
    Garcia-Ramos, Rocio
    Matias-Guiu, Jordi A.
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (02) : 705 - 717
  • [22] NEUROSTEROID AND GABA-A RECEPTOR ALTERATIONS IN ALZHEIMER'S DISEASE, PARKINSON'S DISEASE AND MULTIPLE SCLEROSIS
    Luchetti, S.
    Huitinga, I.
    Swaab, D. F.
    NEUROSCIENCE, 2011, 191 : 6 - 21
  • [23] Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor
    Cochrane, Graham D.
    Rizvi, Syed
    Abrantes, Ana
    Crabtree, Brigid
    Cahill, Jonathan
    Friedman, Joseph H.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (10) : 1145 - 1147
  • [24] Unraveling the Epigenetic Landscape: Insights into Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis
    Di Martino, Pierpaolo
    Marcozzi, Valentina
    Bibbo, Sandra
    Ghinassi, Barbara
    Di Baldassarre, Angela
    Gaggi, Giulia
    Di Credico, Andrea
    BRAIN SCIENCES, 2024, 14 (06)
  • [25] Trends in Parkinson's disease related mortality in England and Wales, 1993-2006
    Mylne, A. Q. N.
    Griffiths, C.
    Rooney, C.
    Doyle, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (09) : 1010 - 1016
  • [26] Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
    Carmona, Asuncion
    Carboni, Eleonora
    Gomes, Lucas Caldi
    Roudeau, Stephane
    Maass, Fabian
    Lenz, Christof
    Ortega, Richard
    Lingor, Paul
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (02) : 128 - 141
  • [27] Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation
    Delalic, Sentilija
    Rus, Tomaz
    Ledinek, Alenka Horvat
    Kojovic, Maja
    Georgiev, Dejan
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 3
  • [28] Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study
    Nielsen, N. M.
    Pasternak, B.
    Stenager, E.
    Koch-Henriksen, N.
    Frisch, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (01) : 107 - 111
  • [29] Still's Disease Mortality Trends in France, 1979-2016: A Multiple-Cause-of-Death Study
    Borciuch, Caroline
    Fauvernier, Mathieu
    Gerfaud-Valentin, Mathieu
    Seve, Pascal
    Jamilloux, Yvan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [30] Patterns of balance loss with systematic perturbations in Parkinson's disease and multiple sclerosis
    Allen, Diane D.
    Gadayan, Jessica
    Hughes, Rebecca
    Magdalin, Christine
    Jang, Catherine
    Schultz, Amy
    Scott, Kathryn
    Vivero, Leah
    Lazaro, Rolando L.
    Widener, Gail L.
    NEUROREHABILITATION, 2021, 49 (04) : 607 - 618